World of DTC Marketing

MAY 26, 2021

net revenue for Imbruvica has increased from $492 million in 2014 to $4.3 billion in Imbruvica net revenue from Medicare Part D between 2014 and 2018. Contrary to the stated purpose of the ODA, AbbVie sought orphan drug protections for Humira even though it was a blockbuster drug with billions of dollars in sales each year.

Competition 180

Competition Marketing Government Patients 180

PharmExec

MARCH 13, 2024

Data shows that from 2014-2019, pneumococcal vaccinations in seniors increased by 10%, growing sales for Prevnar 13 due to government recommendation in addition to a high-profile advertising campaign.

Government 52

Government Pharmaceutical Sales 52

Spotio

AUGUST 3, 2022

SPOTIO is a Dallas-based SaaS platform that enables field sales teams to become more efficient and productive since they began operations in 2014.

Sales 52

Sales 52

Spotio

FEBRUARY 21, 2023

They cite a 24% increase in drug costs per hospital admission in 2014 and a 12% increase in 2015. Home healthcare won’t directly impact medical device sales. Better health outcomes will drive sales. Under current safe harbor definitions, medical device sales aren’t affected by value-based reimbursement.

Medical sales 52

Medical sales Sales Medical Physicians 52

pharmaphorum

OCTOBER 24, 2022

Companies who are thinking about seeking funding via England’s new Innovative Medicines Fund (IMF) need to think through all the commercial implications, including whether spending in the IMF counts towards rebates made against sales through the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS).

Medicine 75

Medicine Sales Specialization Marketing 75

World of DTC Marketing

JUNE 5, 2021

Research published by the World Health Organization found that a rise in fast food sales correlated to a rise in body mass index, and Americans are notorious for their fast-food consumption ? Consumption of added fats also shot up by around two thirds over the same period, and grain consumption rose 45% since 1970. Colon and rectum.

Government 193

Government Medicine Food Management 193

Spotio

AUGUST 15, 2023

You’re a field sales rep, so you spend a lot of time on the road, traveling from one prospect to the next. The best sales podcasts will help make sure you do. Of course, not every sales podcast is created equal. That’s why we’ve put together this list of the best sales podcasts of 2023 for you.

Sales 52

Sales B2B Sales Sales pipeline Prospecting 52

pharmaphorum

AUGUST 16, 2022

First approved in 2014, the drug is also used for a range of indications across ovarian, breast, fallopian tube, peritoneal and pancreatic cancers, and remains one of AZ’s fastest growing oncology therapies, with sales rising 18% to almost $1.3 billion in the first half of this year.

FDA 111

FDA Patients Sales Marketing 111

European Pharmaceutical Review

JANUARY 18, 2024

In its report on the insomnia market published last month, GlobalData expected that sales for DORAs, which offer a new mechanism of action for the condition, will continue to grow at a CAGR of 8.6 million in sales by 2032. percent sales expected in 2032 within the seven major markets. percent between 2022 and 2032.

Marketing 98

Marketing Sales Pharmacology Pharma 98

Rep-Lite

FEBRUARY 26, 2021

The medtechs that enjoy the highest sales for their headcount tend to be those making large, expensive machines or largely genericized orthopedic implants – the types of product that tend to require relatively little in the way of R&D expenditure. Welcome to the calm before the Covid-19 storm.

Sales 52

Sales Retail Government Medical 52

Quantified

DECEMBER 5, 2023

If your business has been around long enough, you likely remember the days of sales in the field, knocking on doors and pounding pavement to drum up leads. Over the years, however, there have been innovations and transformations in how your sales teams cold call, nurture, present to, and close new customers.

Sales 52

Sales Training Sales process Sales Management 52

pharmaphorum

OCTOBER 26, 2022

First approved back in 2014, it is still growing strongly, with its 2021 sales of €2.5 Boehringer is a well-established presence in the IPF treatment market with Ofev (nintedanib), one of the German drugmaker’s top-selling drugs.

Recruitment 98

Recruitment Prospecting Marketing Patients 98

Evolve Your Success

JUNE 28, 2022

In this second segment of a two-part interview, serial entrepreneur Jeff Smith shares how he found his passion and mission through pharmaceutical sales. Pharma Sales To Med Device CEO: The Jeff Smith Story Part 2. Medical sales reps are also seen as a way to be a better resource to their customers. We had $5 million in sales.

Sales 52

Sales Pharma Medical sales reps Medical sales 52

Pharmaceutical Technology

MAY 19, 2023

Rituxan received its first FDA approval in 1997 for the treatment of B-cell non-Hodgkin’s lymphoma (B-NHL) and reached peak global sales of $7.5bn in 2014. Rituximab biosimilars have since achieved notable commercial success, with global sales surpassing $900m collectively.

Sales 59

Sales Competition Marketing Patients 59

Evolve Your Success

MAY 23, 2023

Virtual reality is not just a game-changer for medical sales, but a life-changer for all of us. In this episode, Samuel Adeyinka interviews David Howe to explore the world of virtual reality training for medical device sales reps. I love talking about medical devices, software, sales and business. Samuel, I’m doing great.

Training 52

Training Sales Medical Medical sales 52

Evolve Your Success

JANUARY 2, 2024

Learn all about it from the lens of surgical tech sales with Jennifer McLaughlin. Jennifer also shares her inspiring journey in the medical sales industry, breaking down several tips on becoming an effective and relatable brand ambassador. How big are the sales teams for that type of product? I hope you enjoy this interview.

Sales 52

Sales Training Medical sales Management 52

European Pharmaceutical Review

JUNE 8, 2023

1 In the EU, the Tobacco Products Directive (2014/40/EU) governs “the manufacture, presentation and sale of tobacco and related products”. The harmful effects of smoking are well known, causing more avoidable deaths than any other single cause. Internet] OJEU. Cited 2022Mar].

Food and Drug Administration 59

Food and Drug Administration FDA Manufacturing Law & Regulation 59

pharmaphorum

NOVEMBER 17, 2022

The 2019 VPAS , just like its predecessor that was in place from 2014, has at its heart a payback mechanism. The DHSC said that this was an exceptional change, reflecting the rapid growth in sales in 2021 driven in part by COVID-19. Initial forecast growth rate of measured sales. Actual growth rate of measured sales.

Government 98

Government Sales Medicine Consulting 98

pharmaphorum

NOVEMBER 22, 2022

He was head of Sandoz – Novartis’ soon to be spun off generics business – between 2014 and 2019, and previously spent 12 years at Biogen, ending up as president and head of Biogen US, where he oversaw the launch of multiple sclerosis blockbuster Tecfidera (dimethyl glutamate).

Sales 59

Sales Medicine FDA Pharma 59

pharmaphorum

JANUARY 24, 2023

A just-published report from the Medicines Manufacturing Industry Partnership (MMIP) – set up by the UK government and biopharma industry in 2014 to drive growth in the category – says the sector has the potential to be a driver for the UK economy in the next decade.

Manufacturing 111

Manufacturing Medicine Government Pharmaceutical manufacturing 111

Evolve Your Success

FEBRUARY 6, 2024

Mark Copeland joins Samuel Adeyinka to share his medical sales experience in sterile processing and infection prevention. — Watch the episode here Listen to the podcast here Medical Sales In Sterile Processing And Infection Prevention With Mark Copeland We have with us another special guest and he goes by the name of Mark Copeland.

Medical sales 59

Medical sales Medical Sales Doctors 59

pharmaphorum

SEPTEMBER 14, 2022

It’s worth recalling that Dekkers first announced his intention to step down in 2014, with Baumann elevated to the role of chef strategy and portfolio officer shortly afterwards to prepare him to take on the top job two years later.

Pharma 98

Pharma Management Leads Marketing 98

pharmaphorum

DECEMBER 15, 2022

of total sales – under the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) introduced in 2019. ” Since 2014, the repayment percentage detailed in the VPAS and predecessor the PPRS average at around 7%, before skyrocketing to 19% in 2022 ahead of a government agreed cap at 15%. The increase to 26.5%

Pharma 72

Pharma Government Manufacturing Medicine 72

Legacy MEDSearch

JUNE 15, 2023

Founded in 2014, the company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology. Cala Health’s products are the only FDA-cleared, clinically validated non-invasive devices for the relief of hand tremors so patients with essential tremor can return to the moments that matter.

Patients 98

Patients Recruitment Pharmacology Management 98

pharmaphorum

JULY 9, 2014

The global pharmaceutical market passes a significant milestone in 2014: reaching one trillion US dollars in total value. This study indicates that in the wider global context, the UK still matters for launch as one of the lead developed markets which account for the overwhelming majority of the early years of new chemical entity sales.

Marketing 52

Marketing Digital Media Pharma Engineering 52

Pharmaceutical Technology

JULY 8, 2022

In December 2014, Amgen’s landmark FDA approval saw Blincyto (blinatumomab) approved for relapsed/refractory (R/R) B-cell progenitor acute lymphoblastic leukaemia (B-ALL), at the time being the only marketed BiTE. Currently, there are 110 BiTEs in oncology clinical trials, with seven in Phase III and three in pre-registration.

Safety 59

Safety Sales Marketing Patients 59

Pharmaceutical Technology

OCTOBER 5, 2022

Between 2009 and 2014, the time period of Biogen’s alleged misconduct, the standard of care for MS involved the use of Biogen’s immunomodulatory drugs such as Avonex (Interferon beta-1a), Tecfidera (dimethyl fumarate), and Tysabri (natalizumab). Ferry describes a popular solution among pharmaceutical companies.

Government 59

Government Specialization Physicians Education 59

pharmaphorum

NOVEMBER 11, 2022

Viehbacher led Sanofi between 2008 and 2014 and has decades of experience with both large pharmaceutical companies and small biotechs. However, in 2014 Sanofi fired Viehbacher over a boardroom fight regarding his management. Biogen’s shares rose 2.4% to $289.01 in pre-market trading following the announcement.

Insurance 40

Insurance Doctors FDA Pharma 40

Pharmaceutical Technology

FEBRUARY 22, 2023

Since April 2020, Sanofi is responsible for Praluent outside of the US, while Regeneron handles its sale in the US. Amgen sued the two companies in 2014 over supposed patent infringement. This lowers the levels of low-density lipoprotein (LDL) cholesterol, which is colloquially known as the “bad” cholesterol.

Pharma 104

Pharma Government FDA Sales 104

European Pharmaceutical Review

AUGUST 23, 2022

On- or in-dose authentication means that a security measure or anticounterfeit feature is integrated with the dosage form itself, offering product verification and traceability embedded into each medicine, rather than on the secondary package” WHO estimates that >50 percent of the drugs for sale on the internet are fake.

Medicine 98

Medicine Food and Drug Administration Pharmaceutical products Pharmaceutical 98

Pharmaceutical Technology

MARCH 30, 2023

Broadening uses and secured full approvals Since its first approval in September 2014, Keytruda has achieved blockbuster status on the market. In 2022, the company reported Keytuda sales of $20.9 In 2022, the company reported Keytuda sales of $20.9 billion in its FY 2022 results. billion in its FY 2022 results. billion in 2028.

Food and Drug Administration 52

Food and Drug Administration FDA Sales Food 52

pharmaphorum

NOVEMBER 14, 2022

IQVIA examined the top 100 companies by global sales revenue (IQVIA MIDAS) and extracted data on commitments and progress (Figure 1). A study of public tenders for prescription medicines between 2014 and 2019 shows a fall in multi-criteria tenders rewarding “environmental” attributes and an average weighting of only 5% (see Figure 2).

Medicine 105

Medicine Pharmaceutical Healthcare Healthcare 105

pharmaphorum

DECEMBER 29, 2022

The case revolves around allegations that Novartis made an agreement in 2011 with Par Pharmaceutical when Exforge (valsartan/amlodipine) was nearing the end of its patent life that was designed to keep Par’s generic version of the drug off the market until 30 September, 2014.

Retail 52

Retail Marketing Doctors Government 52

pharmaphorum

AUGUST 19, 2022

Takeda’s drug has been widely tipped to become the dominant option for HAE attack prevention and make blockbuster sales, and is on course to achieve that, with sales in the three months ended 30 June this year approaching $250 million. It is administered as an intravenous injection.

Sales 52

Sales Pharma Patients Medicine 52

The Brooks Group

OCTOBER 3, 2017

Sales managers must prepare their salespeople for approaching these complex buying environments with confidence, and that starts with understanding the roles that exist within a buying committee. in late 2014. In today’s complex selling environment, your sales team needs a strategic approach in order to be successful.

Sales 49

Sales Sales Management Competition Management 49

pharmaphorum

SEPTEMBER 5, 2022

.” The CMA claims Alliance appointed Focus as its distributor for prochlorperazine, also used to treat dizziness and migraines, and Lexon and Medreich were given a share of the profits from sales of the drug after agreeing not to compete in the supply of soluble prochlorperazine tablets in the UK.

Pharma 59

Pharma Competition Management Marketing 59

pharmaphorum

SEPTEMBER 27, 2022

The suit claimed that Biogen paid millions of dollars to doctors in the form of speaker honoraria, training fees, consulting fees, and meals to induce them to prescribe the MS drugs Avonex (interferon-beta-1a), Tysabri (natalizumab), and Tecfidera (dimethyl fumarate) between 2009 and 2014.

Government 45

Government Doctors Consulting Training 45